Blog Archives

BÜHLMANN fCAL® turbo FDA cleared

We are proud to announce the United States Food and Drug Administration (FDA) 510(k) clearance for the BÜHLMANN fCAL® turbo.

Continue Reading →

IBD Monitoring

Find here an update about monitoring of IBD patients.

Continue Reading →

Latest IBDoc® Publications from ECCO 2019

Fecal calprotectin home tests offer patients practical solutions to reduce time spent in hospitals for monitoring disease activity. We present here two poster presentations from the ECCO 2019 about IBDoc®.

Continue Reading →